Cite
HARVARD Citation
Näslund, U. et al. (2019). Visualization of asymptomatic atherosclerotic disease for optimum cardiovascular prevention (VIPVIZA): a pragmatic, open-label, randomised controlled trial. Lancet. 393 (10167), pp. 133-142. [Online].